![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 31/4995 | (2006.01) |
A61K 31/4995 | (2013.01) | ||
A61K 31/554 | (2006.01) | ||
A61P 1/16 | (2018.01) | ||
A61K 31/7042 | (2006.01) | ||
A61P 17/04 | (2018.01) | ||
A61K 38/05 | (2006.01) | ||
A61K 31/7042 | (2013.01) | ||
A61P 1/16 | (2006.01) | ||
A61K 31/554 | (2013.01) | ||
A61P 17/04 | (2006.01) | ||
A61K 38/05 | (2013.01) |
(11) | Patento numeris | 3923943 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 20755296.9 |
Europos patento paraiškos padavimo data | 2020-02-12 | |
(97) | Europos patento paraiškos paskelbimo data | 2021-12-22 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2024-07-31 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2020/017951 |
Data | 2020-02-12 |
(87) | Numeris | WO 2020/167964 |
Data | 2020-08-20 |
(30) | Numeris | Data | Šalis |
201962804523 P | 2019-02-12 | US | |
201962863904 P | 2019-06-20 | US | |
201962908431 P | 2019-09-30 | US | |
201962932015 P | 2019-11-07 | US |
(72) |
JAECKLIN, Thomas , CH
DORENBAUM, Alejandro , US
|
(73) |
Mirum Pharmaceuticals, Inc. ,
989 E Hillsdale Blvd., Suite 300, Foster City, CA 94404,
US
|
(54) | GENOTYPE AND DOSE-DEPENDENT RESPONSE TO AN ASBTI IN PATIENTS WITH BILE SALT EXPORT PUMP DEFICIENCY |
GENOTYPE AND DOSE-DEPENDENT RESPONSE TO AN ASBTI IN PATIENTS WITH BILE SALT EXPORT PUMP DEFICIENCY |